Wednesday, August 19, 2020 1:21:31 PM
From an overall standpoint, the risk/reward on this Lazar shell looks extremely good at this price level. Either Lazar (at the time he took control of the shell) or the previous management removed/eliminated issued preferred shares that would have made the fully-diluted share structure somewhat less attractive for a reverse merger.
Now with 8+ months of churning around this 1-2 cent area this shell appears to be setting up for some potentially nice gains. Quite a few of the Lazar shells have seen multi-million dollar valuations on the original legacy share positions. And some of those legacy valuations on his shells recently have been extraordinarily high.
So I think the chances of seeing prices somewhere in the 5-10 cent range could be excellent. And a price target in the 10-20 cent range would not be unreasonable depending on the quality and market reaction to the incoming RM and management team.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM